Uploaded September 2026 | Updated November 2026, 11 hours ago
Cancer is a disease that continues to be wide reaching, a leading cause of death and impacts every demographic. In 2026, according to the American Cancer Society, the U.S. expects more than 2.1 million new cancer cases, more than 600,000 deaths and impacts to more than 18 million survivors. As new research is implemented, mortality rates continue to drop and treatment with more targeted therapies reduce the impact on survivors.
In this moderated discussion between leading researchers, Dr. Michael Deininger, the Deputy Director for Team & Transdisciplinary Research at the Rogel Cancer Center and Professor and Division Chief of Hematology and Oncology at the University of Michigan and Dr. Albert Koong, Division Head and Chair of the Department of Radiation Oncology at MD Anderson will share with us the current state of cancer research as well as what promising therapies are on the horizon. They will share concrete examples that make these new scientific advances understandable. Topics will include targeted therapies, RAS inhibitors, precision oncology, immunotherapy, overcoming drug resistance and more. The program will be moderated by Dr. Lia Gore, Professor and Chief of Pediatrics, Medical Oncology and Hematology at the University of Colorado and the Chair in Pediatric Oncology and Co-Director of the Developmental Therapeutics Program at Children’s Hospital Colorado.
CHAPTERS
0:00 Introduction & the Future of Cancer Care
2:00 How AI Is Accelerating Cancer Drug Discovery
7:30 Cancer as a Complex Ecosystem
13:30 Targeting Previously “Undruggable” Cancers
19:30 Can We Prevent Cancer?
25:30 Vaccines That Can Prevent Cancer
30:00 Why Basic Science Research Matters
36:00 Lessons From Patients & Careers in Medicine
41:30 Funding Cancer Research
47:00 Pancreatic Cancer & Advanced Imaging
52:00 Leukemia & Radiopharmaceuticals
57:00 New Hope for Glioblastoma
1:03:00 Why Cancer Becomes Resistant to Treatment
1:09:00 Working With Pharmaceutical Companies
1:12:00 Finding Cutting-Edge Cancer Care
1:15:00 The Future of Cancer Research
#CancerResearch #CancerTreatment #ArtificialIntelligence #PrecisionMedicine #FutureOfMedicine
Cancer is a disease that continues to be wide reaching, a leading cause of death and impacts every demographic. In 2026, according to the American Cancer Society, the U.S. expects more than 2.1 million new cancer cases, more than 600,000 deaths and impacts to more than 18 million survivors. As new research is implemented, mortality rates continue to drop and treatment with more targeted therapies reduce the impact on survivors.
In this moderated discussion between leading researchers, Dr. Michael Deininger, the Deputy Director for Team & Transdisciplinary Research at the Rogel Cancer Center and Professor and Division Chief of Hematology and Oncology at the University of Michigan and Dr. Albert Koong, Division Head and Chair of the Department of Radiation Oncology at MD Anderson will share with us the current state of cancer research as well as what promising therapies are on the horizon. They will share concrete examples that make these new scientific advances understandable. Topics will include targeted therapies, RAS inhibitors, precision oncology, immunotherapy, overcoming drug resistance and more. The program will be moderated by Dr. Lia Gore, Professor and Chief of Pediatrics, Medical Oncology and Hematology at the University of Colorado and the Chair in Pediatric Oncology and Co-Director of the Developmental Therapeutics Program at Children’s Hospital Colorado.
CHAPTERS
0:00 Introduction & the Future of Cancer Care
2:00 How AI Is Accelerating Cancer Drug Discovery
7:30 Cancer as a Complex Ecosystem
13:30 Targeting Previously “Undruggable” Cancers
19:30 Can We Prevent Cancer?
25:30 Vaccines That Can Prevent Cancer
30:00 Why Basic Science Research Matters
36:00 Lessons From Patients & Careers in Medicine
41:30 Funding Cancer Research
47:00 Pancreatic Cancer & Advanced Imaging
52:00 Leukemia & Radiopharmaceuticals
57:00 New Hope for Glioblastoma
1:03:00 Why Cancer Becomes Resistant to Treatment
1:09:00 Working With Pharmaceutical Companies
1:12:00 Finding Cutting-Edge Cancer Care
1:15:00 The Future of Cancer Research
#CancerResearch #CancerTreatment #ArtificialIntelligence #PrecisionMedicine #FutureOfMedicine










